<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>antitumor immunity &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/antitumor-immunity/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 20 Oct 2025 21:22:27 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>antitumor immunity &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Dimethyl Fumarate Boosts Antitumor Immunity in Cervical Cancer</title>
		<link>https://bioengineer.org/dimethyl-fumarate-boosts-antitumor-immunity-in-cervical-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 20 Oct 2025 21:22:04 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antitumor immunity]]></category>
		<category><![CDATA[cervical cancer immunotherapy]]></category>
		<category><![CDATA[Dimethyl fumarate therapy]]></category>
		<category><![CDATA[mtDNA-cGAS-STING pathway]]></category>
		<category><![CDATA[tumor cell reprogramming]]></category>
		<guid isPermaLink="false">https://bioengineer.org/dimethyl-fumarate-boosts-antitumor-immunity-in-cervical-cancer/</guid>

					<description><![CDATA[Recent advancements in cancer immunotherapy have highlighted the importance of creative approaches to reprogramming tumor cells to elicit a robust immune response. A recent study conducted by Jiang et al. explores the potential of dimethyl fumarate (DMF) in transforming cervical cancer cells, thereby amplifying antitumor immunity. This groundbreaking research delves into the underlying mechanisms whereby [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">284046</post-id>	</item>
		<item>
		<title>PinX1 Silencing Boosts Radiotherapy Efficacy in Lung Cancer</title>
		<link>https://bioengineer.org/pinx1-silencing-boosts-radiotherapy-efficacy-in-lung-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 25 Sep 2025 18:25:55 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antitumor immunity]]></category>
		<category><![CDATA[non-small cell lung cancer]]></category>
		<category><![CDATA[PinX1 silencing]]></category>
		<category><![CDATA[radiosensitivity enhancement]]></category>
		<category><![CDATA[radiotherapy efficacy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/pinx1-silencing-boosts-radiotherapy-efficacy-in-lung-cancer/</guid>

					<description><![CDATA[Recent research highlights the potential of targeting PinX1 in the treatment of non-small cell lung cancer (NSCLC), particularly in enhancing radiosensitivity and antitumor immunity. This study, conducted by Qiu et al., addresses a critical understanding of how silencing the PinX1 gene can amplify the effects of radiotherapy. The implications of these findings are vast and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">272342</post-id>	</item>
	</channel>
</rss>
